Tower Research Capital (TRC)’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Buy |
16,025
+7,658
| +92% | +$9.96K | ﹤0.01% | 3657 |
|
|
2025
Q1 | $11.6K | Buy |
8,367
+4,151
| +98% | +$5.77K | ﹤0.01% | 3523 |
|
|
2024
Q4 | $9.66K | Buy |
4,216
+2,518
| +148% | +$5.77K | ﹤0.01% | 3889 |
|
|
2024
Q3 | $4.62K | Sell |
1,698
-5,029
| -75% | -$13.7K | ﹤0.01% | 4474 |
|
|
2024
Q2 | $15.7K | Buy |
6,727
+5,414
| +412% | +$12.7K | ﹤0.01% | 3896 |
|
|
2024
Q1 | $6.16K | Sell |
1,313
-9,095
| -87% | -$42.7K | ﹤0.01% | 4423 |
|
|
2023
Q4 | $50.8K | Buy |
10,408
+7,746
| +291% | +$37.8K | ﹤0.01% | 3126 |
|
|
2023
Q3 | $12.4K | Buy |
2,662
+2,108
| +381% | +$9.8K | ﹤0.01% | 3895 |
|
|
2023
Q2 | $4.09K | Sell |
554
-689
| -55% | -$5.09K | ﹤0.01% | 4964 |
|
|
2023
Q1 | $10K | Sell |
1,243
-377
| -23% | -$3.03K | ﹤0.01% | 4319 |
|
|
2022
Q4 | $16K | Buy |
1,620
+121
| +8% | +$1.2K | ﹤0.01% | 3316 |
|
|
2022
Q3 | $18K | Buy |
1,499
+306
| +26% | +$3.67K | ﹤0.01% | 3998 |
|
|
2022
Q2 | $15K | Sell |
1,193
-411
| -26% | -$5.17K | ﹤0.01% | 4050 |
|
|
2022
Q1 | $17K | Buy |
1,604
+498
| +45% | +$5.28K | ﹤0.01% | 3672 |
|
|
2021
Q4 | $17K | Buy |
1,106
+213
| +24% | +$3.27K | ﹤0.01% | 3827 |
|
|
2021
Q3 | $12K | Sell |
893
-1,905
| -68% | -$25.6K | ﹤0.01% | 4131 |
|
|
2021
Q2 | $54K | Buy |
+2,798
| New | +$54K | ﹤0.01% | 2961 |
|